Literature DB >> 8887029

Relationship between morphological diversity and AgNORs or cathepsin B expression in colorectal cancers.

A Nanashima1, Y Tagawa, T Nakagoe, J E Nishizawa-Takano, K Hatano, T Uchikawa, Y Matsumoto, Y Taniguchi, N Fujise, H Ayabe.   

Abstract

The biological characteristics associated with the morphological diversity of colorectal cancers were investigated to elucidate the causes of this diversity. We examined the proliferative and infiltrating activity of tumor cells, indicated by the mean number of Ag nucleolar organizer region associated proteins (NORs) per nucleus (MNA) and the immunohistochemical response to cathepsin B(CB), in various morphological types of early and advanced colorectal cancers. We examined 73 colorectal cancers obtained by endoscopic and surgical resection. MNA values for sessile and flat-elevated cancers were greater than the values for pedunculate, subpedunculate, and flat-or-depressed early cancers (sessile, P < 0.05). In advanced cancers invading the muscularis propria, protruding cancers showed significantly higher MNA values than small ulcerative cancers (P < 0.01). CB expression increased significantly with the progression of colorectal cancers (P < 0.01), but was not related to morphological diversity in early and advanced cancers. In both sessile and flat cancers, CB expression was higher in moderately differentiated than in well differentiated adenocarcinomas. These results indicate that, in colorectal cancers, protruding early cancers without stalks and protruding advanced cancers have higher proliferative activity than pedunculate or flat early cancers and small ulcerative advanced cancers, respectively, and that CB expression is not associated with morphological diversity, but with depth of invasion and histological differentiation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8887029     DOI: 10.1007/bf02347611

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  34 in total

1.  Small primary adenocarcinomas of the colon and rectum.

Authors:  J S SPRATT; L V ACKERMAN
Journal:  JAMA       Date:  1962-02-03       Impact factor: 56.272

2.  Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level.

Authors:  D Ploton; M Menager; P Jeannesson; G Himber; F Pigeon; J J Adnet
Journal:  Histochem J       Date:  1986-01

3.  Fast-growing cancer of the colon and rectum.

Authors:  A Kasumi; G L Kratzer
Journal:  Am Surg       Date:  1992-06       Impact factor: 0.688

4.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

5.  Nucleolar organiser regions in normal, cirrhotic, and carcinomatous livers.

Authors:  J Crocker; J McGovern
Journal:  J Clin Pathol       Date:  1988-10       Impact factor: 3.411

6.  Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues.

Authors:  M R Buck; D G Karustis; N A Day; K V Honn; B F Sloane
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

7.  Flat adenoma-adenocarcinoma sequence in the colon of rats.

Authors:  C Rubio; J Shetye
Journal:  Dis Colon Rectum       Date:  1994-12       Impact factor: 4.585

8.  [Macroscopic classification and kinetic alternations in the superficial lesion of colorectal neoplasms].

Authors:  J Watari; K Yokota
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1994-11

9.  Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival.

Authors:  E Campo; J Muñoz; R Miquel; A Palacín; A Cardesa; B F Sloane; M R Emmert-Buck
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

10.  Changes in the nuclear distribution of cyclin (PCNA) but not its synthesis depend on DNA replication.

Authors:  R Bravo; H Macdonald-Bravo
Journal:  EMBO J       Date:  1985-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.